Synthesis and characterisation of morin reduced gold nanoparticles and its cytotoxicity in MCF-7 cells

Chemico-Biological Interactions

Volumn 224, Issue , 2014, Pages 78-88

  Kondath, Sindhu ^a   Raghavan, Bhuvanasree Srinivas ^a   Anantanarayanan, Rajaram ^a   Rajaram, Rama ^a  

^a CENTRAL LEATHER RESEARCH INSTITUTE   (India)

Author keywords

Apoptosis; Breast cancer; Gold nanoparticles; Morin; Nanoparticle internalization; Secondary necrosis

Indexed keywords

GOLD; GOLD NANOPARTICLE; MORIN; ANTINEOPLASTIC AGENT; BIOMATERIAL; FLAVONOID; METAL NANOPARTICLE;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BIOCOMPATIBILITY; BLOOD CELL; BREAST EPITHELIUM; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTALLIZATION; DOSE RESPONSE; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MCF 7 CELL LINE; PHYSICAL CHEMISTRY; SPECTRUM; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; ERYTHROCYTE; G2 PHASE CELL CYCLE CHECKPOINT; LYSOSOME; MCF-7 CELL LINE; METABOLISM;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BIOCOMPATIBLE MATERIALS; ERYTHROCYTES; FLAVONOIDS; G2 PHASE CELL CYCLE CHECKPOINTS; GOLD; HUMANS; LYSOSOMES; MCF-7 CELLS; METAL NANOPARTICLES;

EID: 84908541783     PISSN: 00092797     EISSN: 18727786     Source Type: Journal    
DOI: 10.1016/j.cbi.2014.09.025     Document Type: Article

References (64)

1. W. Cai, T. Gao, H. Hong, J. Sun, Applications of gold nanoparticles in cancer nanotechnology, Nanotechnol. Sci. Appl. 1 (2008) 17-32.
2. E.C. Dreaden, A.M. Alkilany, X. Huang, C.J. Murphy, M.A. El-Sayed, The golden age: gold nanoparticles for biomedicine, Chem. Soc. Rev. 41 (2012) 2740-2779.
3. M.S. Khana, G.D. Vishakante, H. Siddaramaiah, Gold nanoparticles: a paradigm shift in biomedical applications, Adv. Colloid Interface Sci. 199-200 (2013) 44-58.
4. P. Mukherjee, R. Bhattacharya, N. Bone, Y.K. Lee, C.R. Patra, S. Wang, L. Liu, C. Secreto, P.C. Banerjee, M.J. Yaszemski, N.E. Kay, D. Mukhopadhyay, Potential therapeutic application of gold nanoparticles in B-chronic lymphocytic leukemia (BCLL): enhancing apoptosis, J. Nanobiotechnol. 5 (2007) 4.
5. S.Y. Choi, S.H. Jang, J. Park, S. Jeong, J.H. Park, K.S. Ock, K. Lee, S.I. Yang, S. Joo, P.D. Ryu, S.Y. Lee, Cellular uptake and cytotoxicity of positively charged chitosan gold nanoparticles in human lung adenocarcinoma cells, J. Nanopart. Res. 14 (2012) 1234.
6. M.E. Selim, A.A. Hendi, Gold nanoparticles induce apoptosis in MCF-7 human breast cancer cells, Asian Pac. J. Cancer Prev. 13 (2012) 1617-1620.
7. C. Freese, C. Uboldi, M.I. Gibson, R.E. Unger, B.B. Weksler, I.A. Romero, P.O. Couraud, C.J. Kirkpatrick, Uptake and cytotoxicity of citrate coated gold nanospheres: comparative studies on human endothelial and epithelial cells, Part. Fibre Toxicol. 9 (2012) 23.
8. R. Bhattacharya, C.R. Patra, R. Verma, S. Kumar, P.R. Greipp, P. Mukherjee, Gold nanoparticles inhibit the proliferation of multiple myeloma cells, Adv. Mater. 19 (2013) 711-716.
9. S. Iravani, Green synthesis of metal nanoparticles using plants, Green Chem. 13 (2011) 2638-2650.
10. R.K. Das, S.K. Brar, Plant mediated green synthesis: modified approaches, Nanoscale 5 (2013) 10155-10162.
11. S. Asthana, S. Chauhan, S. Labani, Breast and cervical cancer risk in india: an update, Indian J. Public Health 58 (2014) 5-10.
12. P. Kumar, N.B. Bolshette, V.S. Jamdade, N.A. Mundhe, K.K. Thakur, K.K. Saikia, M. Lahkar, Breast cancer status in India: an overview, Biomed. Prev. Nutr. 3 (2013) 177-183.
13. C. Amaral, M. Borges, S. Melo, E.T. da Silva, G.C. da Silva, N. Teixeira, Apoptosis and autophagy in breast cancer cells following exmestane treatment, PLoS One 7 (2012) e42398.
14. M. Tampio, P. Markannen, K.A. Puttonen, E. Hagelberg, H. Heikkinen, K. Huhtinen, J. Loikkanen, M. Hirvonen, K.H. Vhakangas, Induction of PUMA-α and down- regulation of PUMA-β expression is associated with benzo(a)pyrene induced apoptosis in MCF-7 cells, Toxicol. Lett. 188 (2009) 214-222.
15. S.R. Aspinall, S. Stamp, A. Davison, B.K. Shenton, T.W.J. Lennard, The proliferative effects of 5-androsterone-3β, 17β-diol and 5αdihydrotestosterone on cell cycle analysis and cell proliferation in MCF-7, T47D and MDAMB231 breast cancer cell lines, J. Steroid Biochem. 88 (2004) 37-51.
16. J.S. Carroll, O.W.J. Prall, E.A. Musgrove, R.L. Sutherland, A pure estrogen antagonist inhibits cyclin E-Cdk2 activity in MCF-7 breast cancer cells and induces accumulation of p130-E2F4 complexes characteristic of quiescence, J. Biol. Chem. 275 (2000) 38221-38229.
17. B.M. Collins-Burow, M.E. Burow, B.N. Duonq, J.A. McLachlan, Estrogenic and antiestrogenic activities of flavonoid phytochemicals through estrogen receptor binding -dependent and -independent mechanisms, Nutr. Cancer 38 (2000) 229-244.
18. S. Quideau, D. Deffieux, C. Douat-Casassus, L. Pouysegu, Plant polyphenols: chemical properties, biological activities, and synthesis, Angew. Chem. Int. Ed. 50 (2011) 586-621.
19. B.S. Vinod, T.T. Maliekal, R.J. Anto, Phytochemicals as chemosensitizers: from molecular mechanism to clinical significance, Antioxid. Redox Signal. 18 (2013) 1307-1348.
20. J. Peterson, P. Lagiou, E. Samoli, A. Lagiou, K. Katsouyanni, C.L. Vecchia, J. Dwyer, D. Trichopoulos, Flavonoid intake and breast cancer risk: a case-control study in Greece, Br. J. Cancer 89 (2003) 1255-1259.
21. R. Nema, P. Jain, S. Khare, A. Pradhan, Flavonoid and cancer prevention - mini review, Res. Pharm. 2 (2012) 46-50.
22. M. Xie, M. Long, Y. Liu, C. Qin, Y. Wang, Characterisation of the interaction between human serum albumin and morin, Biochim. Biophys. Acta 1760 (2006) 1184-1191.
23. J. Venugopal, Morin hydrate: botanical origin, pharmacological activity and its application - a mini review, Pharmacognosy J. 5 (2013) 123-126.
24. S. Kuntz, U. Wenzel, H. Daniel, Comparative analysis of the effects of flavonoids on proliferation, cytotoxicity, and apoptosis in human colon cancer cell lines, Eur. J. Nutr. 38 (1999) 133-142.
25. J. Mohan, A.A. Gandhi, B.C. Bhavya, R. Rashmi, D. Karunagaran, R. Indu, T.R. Santoshkumar, Caspase-2 triggers Bax-Bak-dependent and -independent cell death in colon cancer cells treated with resveratrol, J. Biol. Chem. 281 (2006) 17599-17611.
26. H. Kuo, L. Chang, Y. Lin, H. Lu, J. Yang, J. Lee, J. Chung, Morin inhibits the growth of human leukemia HL-60 cells via cell cycle arrest and induction of apoptosis through mitochondria dependent pathway, Anticancer Res. 27 (2007) 395-406.
27. C. Knuefermann, Y. Lu, B. Liu, W. Jin, K. Liang, L. Wu, M. Schmidt, G.B. Mills, J. Mendelsohn, Z. Fan, HER2/PI-3K/Akt activation leads to a multidrug resistance in human breast adenocarcinoma cells, Oncogene 22 (2003) 3205-3212.
28. V.F. Chekhun, N.Y. Lukyanova, O. Kovalchuk, et al., Epigenetic profiling of multidrug-resistant human MCF-7 breast adenocarcinoma cells reveals novel hyper- and hypomethylated targets, Mol. Cancer Ther. 6 (2007) 1089-1098.
29. S. Zhang, X. Yang, M.E. Morris, Flavanoids are inhibitors of breast cancer resistance protein (ABCG2)-mediated transport, Mol. Pharmacol. 65 (2004) 1208-1216.
30. J.S. Choi, J.P. Burm, Enhanced nimodipine bioavailability after oral administration of nimodipine with morin, a flavonoid, in rabbits, Arch. Pharm. Res. 29 (2006) 333-338.
31. S.M. Pathak, N. Udupa, Pre-clinical evidence of enhanced oral bioavailability of the P-glycoprotein substrate talinolol in combination with morin, Biopharm. Drug Dispos. 31 (2010) 202-214.
32. C. Jullian, T. Orosteguis, F. Pérez-Cruz, P. Sánchez, F. Mendizabal, C. Olea-Azar, Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study, Spectrochim. Acta A 71 (2008) 269-275.
33. J. Zhang, Q. Peng, S. Shi, Q. Zhang, X. Sun, T. Gong, Z. Zhang, Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDs) loaded with morin-phospholipid complex, Int. J. Nanomed. 6 (2011) 3405-3414.
34. L. Wen, X. De-Qian, L. Nian-Ci, H. Tai-Ping, Inhibitory activity of a water-soluble morin derivative on phosphatase of regenerating liver-3, Afr. J. Biotechnol. 11 (2012) 4268-4273.
35. H. Yue, Y. Hu, H. Huang, S. Jiang, B. Tu, Development of morin-conjugated Au nanoparticles: exploring the interaction efficiency with BSA using spectroscopic methods, Spectrochim. Acta A 130 (2014) 402-410.
36. I. Ojea-Jimenez, N.G. Bastus, V. Puntes, Influence of the sequence of the reagents addition in the citrate-mediated synthesis of gold nanoparticles, J. Phys. Chem. C 115 (2011) 15752-15757.
37. A. Boyum, Separation of blood leucocytes, granulocytes and lymphocytes, Tissue Antigens 4 (1974) 269-274.
38. Y. Zhao, X. Sun, G. Zhang, B.G. Trewyn, I.I. Slowing, V.S. Lin, Interaction of mesoporous silica nanoparticles with human red blood cell membranes: size and surface effects, ACS Nano 5 (2011) 1366-1375.
39. K. Sindhu, A. Rajaram, K.J. Sreeram, R. Rajaram, Curcumin conjugated biocompatibility synthesis and its biocompatibility, RSC Adv. 4 (2014) 1808-1818.
40. M.K. Chow, C.F. Zukoski, Gold sol formation mechanisms: role of colloidal stability, J. Colloid Interface Sci. 165 (1994) 97.
41. A.M.. Mendoza-Wilson, H. Santacruz-Ortega, R.R. Balandran-Quintana, Relationship between structure, properties, and the radical scavenging activity of morin, J. Mol. Struct. 995 (2011) 134-141.
42. E. Woznicka, M. Kopacz, M. Umbreit, J. Klos, New complexes of La(III), Ce (III), Pr (III), Nd (III), Sm (III), Eu (III) and Gd (III) ions with morin, J. Inorg. Biochem. 101 (2007) 774-782.
43. Q.K. Panhwar, S. Memon, Synthesis and evaluation of antioxidant and antibacterial properties of morin complexes, J. Coord. Chem. 64 (2011) 2117-2129.
44. A.A. Ansari, Paramagnetic NMR shift, spectroscopic and molecular modelling studies of lanthanide (III)-morin complexes, J. Coord. Chem. 61 (2008) 3869-3878.
45. 198AuNP-EGCg) show efficacy in treating prostate cancer, Proc. Natl. Acad. Sci. 109 (2012) 12426-12431.
46. R. Shukla, S.K. Nune, N. Chanda, K. Katti, S. Mekapothula, R.R. Kulkarni, W.V. Welshons, R. Kannan, K.V. Katti, Soybeans as a phytochemical reservoir for the production and stabilization of bicompatible gold nanoparticle, Small 4 (2008) 1425.
47. P. Arunkumar, H. Vedagiri, K. Premkumar, Rapid bioreduction of trivalent aurum using banana stem powder and its cytotoxicity against MCF-7 and HEK-293 cell lines, J. Nanopart. Res. 15 (2013) 1481.
48. I.M.M. Piano, V.S. Marangoni, R.C.S. de Oliveira, L.M.G. Antunes, V. Zucolotto, Cyto and genotoxicity of gold nanoparticles in human hepatocellular carcinoma and peripheral blood mononuclear cells, Toxicol. Lett. 215 (2012) 119.
49. L.D.S. Kok, Y.P. Wong, T.W. Wu, H.C. Chan, T.T. Kwok, K.P. Fung, Morin hydrate: a potential antioxidant in minimizing the free-radicals-mediated damage to cardiovascular cells by anti-tumor drugs, Life Sci. 67 (2000) 91-99.
50. K. Song, P. Xu, Y. Meng, F. Geng, J. Li, Z. Li, J. Xing, J. Chen, B. Kong, Smart gold nanoparticles enhance killing effect on cancer cells, Int. J. Oncol. 42 (2013) 597-608.
51. R. Shukla, V. Bansal, M. Chaudhary, A. Basu, R.R. Bhasu, M. Sastry, Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic view, Langmuir 21 (2005) 10644-10654.
52. E.C. Cho, Q. Zhang, Y. Xia, The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles, Nat. Nanotechnol. 6 (2011) 385-391.
53. B.D. Chithrani, W.C.W. Chan, Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes, Nano Lett. 7 (2006) 1542-1550.
54. E.C. Cho, Y. Liu, Y. Xia, A simple spectroscopic method for differentiating cellular uptakes of gold nanospheres and nanorods from their mixtures, Angew. Chem. Int. Ed. 49 (2010) 1976-1980.
55. W.H. De Jonga, W.I. Hagens, P. Krystek, M.C. Burger, A.J.A.M. Sips, R.E. Geertsma, Particle size-dependent organ distribution of gold nanoparticles after intravenous administration, Biomaterials 29 (2008) 1912-1919.
56. C. Freese, R.E. Unger, R.C. Deller, M.I. Gibson, C. Brochhausen, H. Klok, C.J. Kirkpatrick, Uptake of poly (2-hydroxypropylmethacrylamide)-coated gold nanoparticles in microvascular endothelial cells and transport across the blood-brain barrier, Biomater. Sci. 1 (2013) 824-833.
57. H. Chen, A. Dorrigan, S. Saad, D.J. Hare, M.B. Cortie, S.M. Valenzuela, In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice, PLoS One 8 (2013) e58208.
58. X. Zhang, D. Wu, X. Shen, P. Liu, N. Yang, B. Zhao, H. Zhang, Y. Sun, L. Zhang, F. Fan, Size-dependent in vivo toxicity of PEG-coated gold nanoparticles, Int. J. Nanomed. 6 (2011) 2071-2081.
59. Y. Pan, S. Neuss, A. Leifert, M. Fischler, F. Wen, U. Simon, G. Schmid, W. Brandau, W. Jahnen-Dechent, Size dependent cytotoxicity of gold nanoparticles, Small 3 (2007) 1941-1949.
60. M.T. Silva, Secondary necrosis: the natural outcome of the complete apoptotic program, FEBS Lett. 584 (2010) 4491.
61. M.T. Silva, A. do Vale, E. Nuno, M.N. dos Santos, Secondary necrosis in multicellular animals: an outcome of apoptosis with pathogenic implications, Apoptosis 13 (2008) 463-482.
62. F. Geng, K. Song, J.Z. Xing, C. Yuan, S. Yan, Q. Yang, J. Chen, B. Kong, Thio-glucose bound gold nanoparticles enhance radio-cytotoxic targeting of ovarian cancer, Nanotechnology 22 (2011) 285101.
63. S.C. Gupta, K. Phromnoi, B.B. Aggarwal, Morin inhibits STAT3 tyrosine 705 phosphorylation in tumor cells through activation of protein tyrosine phosphatase SHP1, Biochem. Pharmacol. 85 (2013) 898-912.
64. J. Brown, J. O'Prey, P.R. Harrison, Enhanced sensitivity of human oral tumours to the flavonol, morin, during cancer progression: involvement of the Akt and stress kinase pathways, Carcinogenesis 24 (2003) 171-177.